Cyclodextrin As A Therapeutic “Drug” For HIV AIDS, Niemann Pick Type C and...
Addi and Cassi’s first round of cyclodextrin infusions have been going smoothly at Renown Regional Medical Center in Reno, Nevada. We’re now into our third day of continuous infusions of hydroxy...
View ArticleCrossing The Blood Brain Barrier – Does Cyclodextrin Make Its Way Into The...
Dr. David Begley, one of the world’s leading blood brain barrier experts at Kings College London is working on a research project we are currently funding on cyclodextrin and the blood brain barrier....
View ArticleCyclodextrins Can Reduce Side Effects of Cancer Drug Treatments
Each day, I learn more about the amazing benefits of cyclodextrins — novel excipients of unexplored potential. Research studies in both humans and animals have shown that cyclodextrins and their...
View ArticleAddi & Cassi Featured in an Incredible Wall Street Journal Story
Pulitzer prize winning journalist Amy Marcus spent 6 years following Addi & Cassi, their doctors, and the science community on our journey to find treatments. In an unprecedented 10 chapter online...
View ArticleNPC Disease and it’s Connection to Ebola
Amy Marcus at the Wall Street Journal has written a short story about the unexpected connection between NPC and Ebola today. It is a fascinating article that provides further compelling evidence about...
View ArticleA Mother’s Quest – Dateline NBC Story 2009
DATELINE Covers FDA Approval of Twins Cyclodextrin Infusions Share this:
View ArticleIn Science, Inspiration Can Come From Unlikely Places
A mom reached out to a scientist with a novel idea for an experiment. Years later, her hunch has blossomed into a published scientific study. By: Amy Dockser Marcus (Wall Street Journal) Updated April...
View ArticleDrug for Rare Disorder Linked to Reducing Cholesterol Plaque
Compound being tested in a genetic condition showed promise in treating heart disease in mice By: Amy Dockser Marcus (Wall Street Journal) Updated April 6, 2016 4:19 p.m. ET Cyclodextrin, a compound...
View Article
